Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni
JAMES JOYCE K.,EICHELBERGER SHAWN R.,SAVALL TRACI L.,JAMES Joyce K.,EICHELBERGER Shawn R.,SAVALL Traci L.
申请号:
SI200831093
公开号:
SI2205244T1
申请日:
2008.11.07
申请国别(地区):
SI
年份:
2013
代理人:
摘要:
Provided herein are methods of administering N -(5- tert -butyl-isoxazol-3-yl)- N '-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Further, pharmaceutical formulations are provided. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.